Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma
- Supplementary File 1:
PDF-Document (PDF, 214 KiB)
Glazar, D.J.; Grass, G.D.; Arrington, J.A.; Forsyth, P.A.; Raghunand, N.; Yu, H.-H.M.; Sahebjam, S.; Enderling, H. Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma. J. Clin. Med. 2020, 9, 2019. https://doi.org/10.3390/jcm9072019
Glazar DJ, Grass GD, Arrington JA, Forsyth PA, Raghunand N, Yu H-HM, Sahebjam S, Enderling H. Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma. Journal of Clinical Medicine. 2020; 9(7):2019. https://doi.org/10.3390/jcm9072019
Chicago/Turabian StyleGlazar, Daniel J., G. Daniel Grass, John A. Arrington, Peter A. Forsyth, Natarajan Raghunand, Hsiang-Hsuan Michael Yu, Solmaz Sahebjam, and Heiko Enderling. 2020. "Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma" Journal of Clinical Medicine 9, no. 7: 2019. https://doi.org/10.3390/jcm9072019